0001104659-20-113579.txt : 20201008
0001104659-20-113579.hdr.sgml : 20201008
20201008202731
ACCESSION NUMBER: 0001104659-20-113579
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201007
FILED AS OF DATE: 20201008
DATE AS OF CHANGE: 20201008
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LLOYD RONALD K.
CENTRAL INDEX KEY: 0001644078
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39577
FILM NUMBER: 201231905
MAIL ADDRESS:
STREET 1: C/O MALLINCKRODT PHARMACEUTICALS
STREET 2: 675 MCDONNELL BLVD.
CITY: HAZELWOOD
STATE: MO
ZIP: 63042
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AZIYO BIOLOGICS, INC.
CENTRAL INDEX KEY: 0001708527
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 474790334
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12510 PROSPERITY DRIVE
STREET 2: SUITE 370
CITY: SILVER SPRING
STATE: MD
ZIP: 20904
BUSINESS PHONE: 240-247-1143
MAIL ADDRESS:
STREET 1: 12510 PROSPERITY DRIVE
STREET 2: SUITE 370
CITY: SILVER SPRING
STATE: MD
ZIP: 20904
4
1
a4.xml
4
X0306
4
2020-10-07
0
0001708527
AZIYO BIOLOGICS, INC.
AZYO
0001644078
LLOYD RONALD K.
C/O AZIYO BIOLOGICS, INC.
12510 PROSPERITY DRIVE, SUITE 370
SILVER SPRING
MD
20904
1
1
0
0
President and CEO
Stock Option (Right to Buy)
17.00
2020-10-07
4
A
0
181783
0.00
A
2030-10-06
Class A Common Stock
181783
181783
D
Restricted Stock Units
2020-10-07
4
A
0
100425
0.00
A
Class A Common Stock
100425
100425
D
This option vests and becomes exercisable in 4 substantially equal annual installments on each of the successive years following October 7, 2020.
Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock.
The restricted stock units will vest in full on October 7, 2023 and do not have an expiration date.
/s/ Ronald Lloyd
2020-10-08